NCT06764095 2026-02-12Enfortumab Vedotin and Pembrolizumab With Cystectomy and/or Ureterectomy for Locally Advanced or Metastatic Bladder and Upper Urothelial Tract Cancer, CAST-AI TrialMayo ClinicPhase 4 Recruiting75 enrolled